Literature DB >> 16020761

Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia.

Roland Veltkamp1, Dirk A Siebing, Li Sun, Sabine Heiland, Katja Bieber, Hugo H Marti, Simon Nagel, Stefan Schwab, Markus Schwaninger.   

Abstract

BACKGROUND AND
PURPOSE: Hyperbaric oxygen (HBO) has been shown to protect the brain parenchyma against transient focal cerebral ischemia, but its effects on the ischemic microcirculation are largely unknown. We examined the potential of HBO to reduce postischemic blood-brain barrier (BBB) damage and edema.
METHODS: Wistar rats and C57/BL6 mice underwent occlusion of the middle cerebral artery (MCAO) for 2 hours. Forty minutes after filament introduction, animals breathed either 100% O2 at 3.0 atmospheres absolute (ata; HBO group) or at 1.0 ata (control) for 1 hour in an HBO chamber. In rats, MRI was performed 15 minutes after MCAO and after 15 minutes and 3, 6, 24, and 72 hours of reperfusion. In mice, BBB permeability for sodium fluorescein was measured after 24-hour reperfusion.
RESULTS: Increased BBB permeability on postcontrast T1-weighted (T1w) images had a biphasic pattern. HBO reduced volumes and intensity of enhancement. Mean abnormal enhancing volumes were 71+/-10 mm3 (control) versus 47+/-10 mm3 (HBO) at 15 minutes; 111+/-21 mm3 versus 69+/-17 mm3 3 hours; 147+/-44 mm3 versus 83+/-21 mm3 6 hours; 150+/-37 mm3 versus 89+/-14 mm3 24 hours; and 322+/-52 mm3 versus 215+/-21 mm3 72 hours (all P<0.05). Interhemispheric quotients of mean gray values on T1w were at 1.73+/-0.11 versus 1.57+/-0.07 15 minutes; 1.74+/-0.07 versus 1.60+/-0.06 at 3 hours; 1.77+/-0.07 versus 1.62+/-0.06 at 6 hours; 1.79+/-0.10 versus 1.60+/-0.05 at 24 hours; and 1.81+/-0.10 versus 1.62+/-0.07 at 72 hours (all P<0.05). HBO-treated mice had significantly lower postischemic BBB permeability than mice treated with either normobaric hyperoxia or room air. Vasogenic edema assessed on T2w images and histologic sections was significantly lower in HBO-treated rats.
CONCLUSIONS: Intraischemic HBO therapy reduces early and delayed postischemic BBB damage and edema after focal ischemia in rats and mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020761     DOI: 10.1161/01.STR.0000173408.94728.79

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  48 in total

1.  Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke.

Authors:  Hwa Kyoung Shin; Fumiaki Oka; Ji Hyun Kim; Dmitriy Atochin; Paul L Huang; Cenk Ayata
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 2.  Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability.

Authors:  Dallan McMahon; Charissa Poon; Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2019-01-29       Impact factor: 6.648

3.  Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury.

Authors:  Fang Hua; Jing Ma; Tuanzhu Ha; Jim Kelley; David L Williams; Race L Kao; John H Kalbfleisch; I William Browder; Chuanfu Li
Journal:  J Neuroimmunol       Date:  2008-06-27       Impact factor: 3.478

4.  Only very early oxygen therapy attenuates posthemorrhagic edema formation and blood-brain barrier disruption in murine intracerebral hemorrhage.

Authors:  Wei Zhou; Marilena Marinescu; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

5.  Effects of hyperbaric oxygen on the expression of claudins after cerebral ischemia-reperfusion in rats.

Authors:  Hong Zhao; Qianru Zhang; Yixue Xue; Xuexin Chen; Randy S Haun
Journal:  Exp Brain Res       Date:  2011-05-31       Impact factor: 1.972

6.  Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair.

Authors:  Nobutaka Horie; Marta P Pereira; Kuniyasu Niizuma; Guohua Sun; Hadar Keren-Gill; Angelo Encarnacion; Mehrdad Shamloo; Scott A Hamilton; Kewen Jiang; Stephen Huhn; Theo D Palmer; Tonya M Bliss; Gary K Steinberg
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

7.  Delayed hyperbaric oxygen therapy induces cell proliferation through stabilization of cAMP responsive element binding protein in the rat model of MCAo-induced ischemic brain injury.

Authors:  Jun Mu; Robert P Ostrowski; Yoshiteru Soejima; William B Rolland; Paul R Krafft; Jiping Tang; John H Zhang
Journal:  Neurobiol Dis       Date:  2012-11-10       Impact factor: 5.996

8.  A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.

Authors:  Grant M Liska; Trenton Lippert; Eleonora Russo; Norton Nieves; Cesar V Borlongan
Journal:  Cond Med       Date:  2018-06

9.  Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.

Authors:  Hiroaki Manabe; David O Okonkwo; John L Gainer; Ryon H Clarke; Kevin S Lee
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

10.  Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Authors:  Daniel A Rossignol; Lanier W Rossignol; Scott Smith; Cindy Schneider; Sally Logerquist; Anju Usman; Jim Neubrander; Eric M Madren; Gregg Hintz; Barry Grushkin; Elizabeth A Mumper
Journal:  BMC Pediatr       Date:  2009-03-13       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.